From pharmAlliance

Introducing PharmAlliance International Labs Private Limited’s Ceftriaxone Sodium Vial Range: Pioneering Antibiotic Therapy

March 4, 2025

Spread the love

Introducing PharmAlliance International Labs Private Limited’s Ceftriaxone Sodium Vial Range: Pioneering Antibiotic Therapy

Thank you for reading this post, don't forget to subscribe!

Welcome to PharmAlliance International Labs Private Limited, where innovation and excellence converge to redefine healthcare standards globally. Our Ceftriaxone Sodium Vial Range stands as a testament to our unwavering commitment to quality, efficacy, and patient-centric care, offering a potent antibiotic solution for a myriad of bacterial infections.

Understanding Ceftriaxone Sodium

PharmAlliance Ceftriaxone Sodium Range, a third-generation cephalosporin antibiotic, is renowned for its broad-spectrum activity against both Gram-positive and Gram-negative bacteria. This versatile antibiotic plays a pivotal role in combating a wide array of infectious diseases, offering a lifeline to patients battling bacterial infections worldwide.

Formulations and Strengths

PharmAlliance Ceftriaxone Sodium Vial Range is available in a variety of strengths to accommodate diverse patient needs and treatment protocols. Our vials contain sterile powder for reconstitution, ensuring flexibility and convenience in dosing administration, and are available in:

250mg
500mg
1000mg (1g)
2000mg (2g)

Indications and Therapeutic Applications

Ceftriaxone is indicated for an extensive range of bacterial infections, including but not limited to:

Lower respiratory tract infections such as pneumonia and bronchitis
Urinary tract infections encompassing cystitis and pyelonephritis
Skin and soft tissue infections, addressing conditions like cellulitis and wound infections
Intra-abdominal infections, including peritonitis and cholecystitis
Bone and joint infections, combating osteomyelitis effectively
Meningitis, providing a crucial therapeutic intervention
Gonorrhea and pelvic inflammatory disease (PID), offering a reliable treatment option

Pharmacokinetics Insights

Absorption: Administered parenterally, Ceftriaxone achieves rapid and extensive plasma concentrations post intramuscular or intravenous injection.
Distribution: The drug exhibits widespread distribution into various bodily tissues and fluids, including but not limited to the lungs, kidneys, liver, and cerebrospinal fluid.
Metabolism: Ceftriaxone undergoes minimal hepatic metabolism, with a significant proportion excreted unchanged in the urine, ensuring potent therapeutic activity.

PharmAlliance International Labs Private Limited—Your trusted partner in surgical excellence.